Stryker announces leadership succession
Stryker announced a planned CEO succession: Spencer Stiles, currently President and COO, will become CEO effective January 1, 2027, succeeding Kevin Lobo, who transitions to Executive Chair. Stiles joined Stryker in 1999 and has led businesses across Orthopaedics, MedSurg and Neurotechnology; he oversaw the Wright Medical acquisition and the spinal implants separation before becoming President and COO in January 2026. Lobo's 14-year tenure tripled net sales from $8.7 billion in 2012 to more than $26 billion in 2026 and included more than 60 acquisitions.
Key figures
- Effective date
- January 1, 2027
- Net sales 2012
- $8.7 billion
- Net sales 2026
- $26 billion
- Acquisitions completed
- more than 60
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.